两种国产支架治疗冠心病疗效和再狭窄率的回顾性研究

被引：3

作者：

陈哲

潘春奇

张邢炜

杨德业

机构：

[1] 杭州师范大学附属医院心内科

来源：

心电与循环 | 2017年 / 36卷 / 01期

关键词：

生物可降解; 药物洗脱支架; 再狭窄; EXCEL支架; PARTNER支架;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

100201 [内科学];

摘要：

目的评价冠心病患者置入国产生物可降解涂层支架(EXCEL)的疗效及再狭窄率方面是否优于国产不可降解涂层支架(PARTNER)。方法 111例冠心病患者行冠状动脉PCI术,其中54例植入EXCEL可降解药物洗脱支架(EXCEL组),57例置入PARTNER永久聚合物药物洗脱支架(PARTNER组)。随访观察两组主要心脏不良事件(MACE)、再发心绞痛、晚期支架内血栓形成、支架内再狭窄率、支架内管径丢失和心力衰竭等。结果临床随访6～30(13.6±6.8)个月,两组MACE以及再发心绞痛、晚期支架内血栓形成、支架内再狭窄率、心脏衰竭等差异无统计学意义(均P>0.05),但EXCEL组的支架内管径丢失≥30%发生率低于PARTNER组(P=0.019)。结论 EXCEL支架与PARTNER支架在治疗冠心病的治疗中有相似的疗效和安全性,但支架内管径丢失率较低。

引用

页码：21 / 24

页数：4

共 7 条

[1]

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Gruntzig Lecture ESC 2014 [J].

Byrne, Robert A. ;

Joner, Michael ;

Kastrati, Adnan .

EUROPEAN HEART JOURNAL, 2015, 36 (47) :3320-+

[2]

Recent advances in drug eluting stents.[J].Amey S. Puranik;Eileen R. Dawson;Nicholas A. Peppas.International Journal of Pharmaceutics.2012,

[3]

Sustained clinical safety and efficacy of a biodegradable-polymer coated sirolimus-eluting stent in "real-world" practice: Three-year outcomes of the CREATE (multi-center registry of EXCEL biodegradable polymer drug eluting stents) study [J].

Han, Yaling ;

Jing, Quanmin ;

Li, Yi ;

Yang, Lixia ;

Liu, Huiliang ;

Shang, Xiaoming ;

Jiang, Tiemin ;

Li, Zhanquan ;

Zhang, Hua ;

Yan, Gaoliang .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) :211-216

[4]

Long-term effectiveness and safety of sirolimus drug-eluting stents.[J].Mahesh Bikkina;Jayanth Koneru.Medical Devices: Evidence and Research.2011, defa

[5]

Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents [J].